|
|
NEW ON THE MARKET
|
|
Infliximab biosimilars INFLECTRA and REMSIMA
Original and biosimilar: no difference?
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
IMPROVE-IT trial with ezetimibe (EZETROL, in INEGY and others)
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
On the frequency of INR measurements during treatment with phenprocoumon
Rota virus vaccination: recommendation versus actual medical care situation
|
|
|
SIDE EFFECTS
|
|
Ketoacidosis with SGLT-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin)
Agranulocytosis with febuxostat (ADENURIC)
|
|
|
e a-t IN INTERNET
|
|
Adverse drug reactions missing from product information: gliptins and bullous pemphigoid, isotretinoin and anal fissure, terbinafine and impotence
Misconduct at study sites - most often not reported in publications
|
|